Institutional Ownership Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR). We have compiled data on the 174 institutions that hold shares in the stock, with a total of 125 Million shares, which have been reported (via 13F filing form) to have a value of $271 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
13,708,731
shares
|
$29.6 Million
0.83% of portfolio
|
Q1 2024
New holding
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
May 15, 2024 Q1 2024 |
9,944,064
shares
|
$21.5 Million
0.42% of portfolio
|
Q1 2024
Added 136.52%
|
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
Apr 18, 2024 Q1 2024 |
9,129,647
shares
|
$19.7 Million
0.13% of portfolio
|
Q1 2024
Added 2.68%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
8,826,546
shares
|
$19.1 Million
0.0% of portfolio
|
Q1 2024
Added 71.8%
|
|
|
Great Point Partners LLC
Greenwich, CT |
May 15, 2024 Q1 2024 |
8,000,000
shares
|
$17.3 Million
5.25% of portfolio
|
Q1 2024
New holding
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2024 Q1 2024 |
7,922,229
shares
|
$17.1 Million
0.2% of portfolio
|
Q1 2024
Added 2628.21%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
5,681,744
shares
|
$12.3 Million
0.01% of portfolio
|
Q1 2024
Added 64.71%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2024 Q1 2024 |
5,143,486
shares
|
$11.1 Million
0.01% of portfolio
|
Q1 2024
Added 323.96%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2024 Q1 2024 |
4,545,260
shares
|
$9.82 Million
0.0% of portfolio
|
Q1 2024
Added 2474.69%
|
|
|
Two Seas Capital LP
Rye, NY |
May 15, 2024 Q1 2024 |
4,165,657
shares
|
$9 Million
5.73% of portfolio
|
Q1 2024
Reduced 45.8%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2024 Q1 2024 |
3,975,560
shares
|
$8.59 Million
0.03% of portfolio
|
Q1 2024
Added 70.3%
|
|
|
Meditor Group LTD
|
Apr 11, 2024 Q1 2024 |
3,791,300
shares
|
$8.19 Million
14.93% of portfolio
|
Q3 2023
Reduced 13.89%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2024 Q1 2024 |
3,569,700
shares
|
$7.71 Million
0.02% of portfolio
|
Q1 2024
Added 66.3%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
3,364,266
shares
|
$7.27 Million
0.0% of portfolio
|
Q1 2024
Added 218.16%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
3,362,210
shares
|
$7.26 Million
0.0% of portfolio
|
Q1 2024
Added 627.31%
|
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
2,838,820
shares
|
$6.13 Million
0.0% of portfolio
|
Q1 2024
Added 34.36%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2024 Q1 2024 |
2,215,961
shares
|
$4.79 Million
0.01% of portfolio
|
Q1 2024
Added 384.09%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
2,116,500
shares
|
$4.57 Million
0.01% of portfolio
|
Q1 2024
Added 49.04%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
2,085,101
shares
|
$4.5 Million
0.0% of portfolio
|
Q1 2024
Added 11.95%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 07, 2024 Q1 2024 |
2,045,769
shares
|
$4.42 Million
0.0% of portfolio
|
Q1 2024
Added 47.15%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
1,753,193
shares
|
$3.79 Million
0.0% of portfolio
|
Q1 2024
Added 57.63%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,642,360
shares
|
$3.55 Million
0.0% of portfolio
|
Q1 2024
Added 48.63%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 14, 2024 Q1 2024 |
1,607,312
shares
|
$3.47 Million
0.01% of portfolio
|
Q1 2024
Added 269.29%
|
|
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
May 13, 2024 Q1 2024 |
1,597,542
shares
|
$3.45 Million
0.18% of portfolio
|
Q1 2024
Reduced 43.16%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2024 Q1 2024 |
1,142,897
shares
|
$2.47 Million
0.42% of portfolio
|
Q1 2024
Reduced 19.81%
|
|